
A NEW IDEA ON BIOTECH MARAVAI — SUPPLIES A KEY COMPONENT OF CORONAVIRUS VACCINE
Maravai LifeSciences (MRVI) supplies a key component of the coronavirus vaccine produced by Pfizer (PFE) and BioNTech (BNTX). The vaccine should provide a sharp increase in revenue. The company also has a diversified product portfolio. Zones For those following the Good Way, the Buy Now rating is ‘YES.’ For those following the Best Way the buy zone is $23 to $26.76. MRVI is trading at $26.31 as of this writing in the premarket. The stop zone is $21.38 to $22.33. The first target zone is $29 to $32. The second target zone is $35 to $38. The maximum quantity is